DDW Highlights: 10 July 2023

<p><span data-contrast="none">The latest episode of the <a href= "https://www.ddw-online.com/t/ddw-highlights-podcast/">DDW Highlights podcast</a> is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. </span></p> <p>It’s been a fascinating week in drug discovery, as AstraZeneca announced that its Phase III trial of datopotamab deruxtecan did not meet its second primary endpoint and saw an 8% drop in its stock market value as a result.</p> <p>In other headline news, the FDA approved the first cellular therapy for type 1 diabetes which could allow some patients to become insulin-independent, and a new study linked severe Covid-19 outcomes with high levels of antibiotics use.</p> <p><span data-contrast="auto">You can listen below, or find The Drug Discovery World Podcast on</span> <a href= "https://open.spotify.com/show/5HpeK1T3H1VQIB1fiwn0KQ"><span data-contrast="none"> Spotify</span></a><span data-contrast="none">,</span> <a href= "https://play.google.com/store/apps/details?id=com.edify.ddw"><span data-contrast="none"> Google Play</span></a> <span data-contrast="auto">and</span> <a href= "https://apps.apple.com/gb/app/drug-discovery-world-ddw/id1530786395"> <span data-contrast="none">Apple Podcasts.</span></a><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p>